Skip to main content
Log in

Effect of antisense oligodeoxynucleotide directed to NF-κB-RelA on Bcl-xL mRNA in extended drug resistance leukemia cell line HL-60/E6

  • Published:
Current Medical Science Aims and scope Submit manuscript

Summary

To explore the effect of NF-κB on bcl-x gene transcription in extended drug resistance leukemia cell line HL-60/E6, drug-resistant subline HL-60/E6 was derived by intermittently exposing HL-60 cells to 6 ng/ml epirubicin. Indirect immunofluorescence was used to demonstrate the location of NF-κB-RelA in HL-60/E6 cells. FCM analysis and RT-PCR were used to detect the efficiency of liposome-mediated ODN transfection and the change of bcl-XL. mRNA levels after 5 μmol/L phosphorothioate (PS)-derivatized antisense (AS) oligodeoxynucleotide (ODN) directed to RelA was transferred into HL-60/E6 cells. The results showed that RelA remained persistently active and located at the nuclei of HL-60/E6 cells, but in the cytoplasm of HL-60 cells, the efficiency of liposomemediated ODN transfection was significantly higher than that of null ODN (P<0. 01 in 4 h, 6 h, 12 h, 24 h). Exposure of HL-60/E6 cells to 5 μmol/L AS-PS-ODN directed to RelA led to a maximal 40 % decline of bcl-xL mRNA levels within 8 h. The inhibition rate of bcl-XL. mRNA was (15±1. 79) %, (28±2. 34) %, (40±3.47) %, (20±1.54) % in 4 h,6h,8h, 15 h, respectively, but it was less than 15 % in control group. It was concluded that NF-κB was involved in regulating bcl-x transcription. It was suggested that NF-κB was an important factor for drug resistance in leukemia cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Chen F, Castranova V, Shi Xet al. New insights into the role of nuclear factor-κB, a ubiquitous transcription factor in the initiation of diseases. Clin Chem, 1999, 45: 7

    Article  CAS  PubMed  Google Scholar 

  2. Reed J C. Double identity for proteins of the Bcl-2 family. Nature, 1997, 387: 773

    Article  ADS  CAS  PubMed  Google Scholar 

  3. Lee H H, Dadgostar H, Cheng Qet al. NF-κB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc Natl Acad Sci USA, 1999, 96: 9136

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  4. Kawasaki A M, Casper M D, Freier S Met al. Uniformly modified 2′-deoxy-2′-fluorophosphorothioate oligonucleotides as nuclease-resistant antisense compounds with high affinity and specificity for RNA targets. J Med Chem, 1993, 36: 831

    Article  CAS  PubMed  Google Scholar 

  5. Reuning U, Wilhelm O, Nishiguchi Tet al. Inhibition of NF-κB-RelA expression by antisense oligodeoxynucleotides suppression synthesis of urokinase-type plasminogen activator (uPA) but not its inhibitor PAI-1. Nucleic Acids Res, 1995, 23: 3887

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wenjing, C., Yaozhen, Z., Donghua, Z. et al. Effect of antisense oligodeoxynucleotide directed to NF-κB-RelA on Bcl-xL mRNA in extended drug resistance leukemia cell line HL-60/E6. Current Medical Science 21, 32–34 (2001). https://doi.org/10.1007/BF02888031

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02888031

Key words

Navigation